News

WEEK IN REVIEW UPDATES TO THE LIVING GUIDELINE New recommendation for tocilizumab in children or adolescents Further to the Taskforce's recent recommendation for the conditional use of tocilizumab for adults (25 February 2021), the Paediatric and Adolescent Care Panel have reviewed the evidence in the context of this special population, also consulting with members of the Expert Advisory Group in rheumatology, immunotherapy and paediatric...

WEEK IN REVIEW Updates to the living guideline Three new recommendations have been published this week covering: Bamlanivimab Fluvoxamine Intravenous immunoglobulin VTE prophylaxis for children and adolescents Further details are...

WEEK IN REVIEW BREAKING NEWS: Australian-led REMAP-CAP Trial reports benefit of tocilizumab for critically ill patients with COVID-19. The REMAP-CAP investigators led by Prof Steve Webb, Monash University, have this...

WEEK IN REVIEW New recommendations for children and adolescents, and pregnant women The Paediatric and Adolescent Care Panel have developed two new consensus recommendations for respiratory support covering...

WEEK IN REVIEW New recommendations for Child and Adolescent Care It has been a busy week for the Child and Adolescent Care Panel with two new consensus recommendations...